Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SSR4 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IDH3G - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SRPK3 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
PDZD4 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
PLXNB3 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ABCD1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
L1CAM - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
BCAP31 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SLC6A8 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SLC6A10P - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SLC6A10PB - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
AVPR2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ARHGAP4 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
NAA10 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
RENBP - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
HCFC1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on